tiprankstipranks
Trending News
More News >
BioMark Diagnostics (TSE:BUX)
:BUX
Canadian Market

BioMark Diagnostics (BUX) Income Statement

Compare
3 Followers

BioMark Diagnostics Income Statement

Last quarter (Q1 2026), BioMark Diagnostics's total revenue was C$38.99K, an increase of 1.77% from the same quarter last year. In Q1, BioMark Diagnostics's net income was C$-416.01K. See BioMark Diagnostics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 24Dec 22Dec 21Dec 20
Total Revenue
C$ 154.22KC$ 163.22KC$ 153.49KC$ 43.93KC$ 0.00
Gross Profit
C$ 154.22KC$ 163.22KC$ -232.70KC$ 43.93KC$ -13.69K
Operating Expenses
C$ 2.06MC$ 1.48MC$ 1.89MC$ 1.45MC$ 1.08M
Depreciation and Amortization
C$ 401.27KC$ 393.17KC$ 386.20KC$ 179.62KC$ 13.69K
EBITDA
C$ -1.46MC$ -919.05KC$ -1.35MC$ -1.22MC$ -1.08M
Operating Income
C$ -1.91MC$ -1.32MC$ -1.84MC$ -1.28MC$ -1.09M
Other Income/Expenses
C$ -19.14KC$ -110.67KC$ -110.15KC$ -50.80KC$ -596.00
Pretax Income
C$ -1.93MC$ -1.43MC$ -1.84MC$ -1.45MC$ -1.09M
Net Income
C$ -1.93MC$ -1.43MC$ -1.84MC$ -1.45MC$ -1.09M
Per Share Metrics
Basic EPS
C$ -0.02C$ -0.02C$ -0.02C$ -0.02C$ -0.01
Diluted EPS
C$ -0.02C$ -0.02C$ -0.02C$ -0.02C$ -0.01
Weighted Average Shares Outstanding
85.24M 85.24M 82.78M 72.31M 73.30M
Weighted Average Shares Outstanding (Diluted)
85.24M 85.24M 82.78M 72.31M 73.30M
Currency in CAD

BioMark Diagnostics Earnings and Revenue History